Xiaozhi Li

58 Zhongshan II Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

DUOX2-Driven Oxidative Stress Alters the Gut Redox Niche and Promotes Microbial Dysbiosis in Crohn's Disease.

DUOX2-Driven Oxidative Stress Alters the Gut Redox Niche and Promotes Microbial Dysbiosis in Crohn's Disease.

Journal: Antioxidants (Basel, Switzerland)

Published: December 17, 2025

Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system.

Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system.

Journal: International journal of clinical pharmacy

Published: November 09, 2025

New Onset Heart Failure Induced by Glumetinib: A Case Report.

New Onset Heart Failure Induced by Glumetinib: A Case Report.

Journal: Clinical therapeutics

Published: September 18, 2025

Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database.

Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database.

Journal: Frontiers in pharmacology

Published: September 06, 2025

Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice.

Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice.

Journal: Critical reviews in oncology/hematology

Published: September 04, 2025

Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights.

Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights.

Journal: Frontiers in oncology

Published: May 30, 2025

Gut Microbiota as a Mediator Between Intestinal Fibrosis and Creeping Fat in Crohn's Disease.

Gut Microbiota as a Mediator Between Intestinal Fibrosis and Creeping Fat in Crohn's Disease.

Journal: United European gastroenterology journal

Published: November 13, 2024

Decoding polyphenol metabolism in patients with Crohn's disease: Insights from diet, gut microbiota, and metabolites.

Decoding polyphenol metabolism in patients with Crohn's disease: Insights from diet, gut microbiota, and metabolites.

Journal: Food research international (Ottawa, Ont.)

Published: May 31, 2024

Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn's disease development.

Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn's disease development.

Journal: Microbiome

Published: March 27, 2024

A Novel Serum Metabolomic Panel for the Diagnosis of Crohn's Disease.

A Novel Serum Metabolomic Panel for the Diagnosis of Crohn's Disease.

Journal: Inflammatory bowel diseases

Published: January 04, 2023

Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Model Possibly via Platelet Activation.

Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Model Possibly via Platelet Activation.

Journal: Journal of Crohn's & colitis

Published: December 30, 2022

Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study.

Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study.

Journal: BMC medicine

Published: November 12, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026